Beconase Aq

  • Rhinitis/rhinorrhea (intranasal products)

Beconase Aq Generic Name & Formulations

General Description

Beclomethasone dipropionate 42mcg/spray; aqueous nasal spray.

Pharmacological Class


How Supplied

Nasal spray—25g (180 sprays)


Beconase Aq Indications


Allergic and vasomotor rhinitis. Prophylaxis of nasal polyp recurrence.

Beconase Aq Dosage and Administration

Adults and Children

<6yrs: not recommended. ≥6yrs: 1–2 sprays in each nostril twice daily; max 2 sprays in each nostril twice daily. Reevaluate if no improvement in 3 weeks; nasal polyp prophylaxis may warrant longer treatment.

Beconase Aq Contraindications

Not Applicable

Beconase Aq Boxed Warnings

Not Applicable

Beconase Aq Warnings/Precautions


Avoid in recent nasal septal ulcers, nasal surgery, or nasal trauma until healed. Monitor periodically for possible changes in nasal mucosa with long-term use. Discontinue if persistent nasopharyngeal irritation or Candida infection (treat with local therapy) occurs. Respiratory tract tuberculosis. Untreated infections (eg, fungal, bacterial, viral, ocular herpes simplex). If exposed to chickenpox or measles, consider immune globulin or antiviral ­prophylactic therapies. Monitor for hypercorticism and HPA axis suppression (if occurs, discontinue gradually), growth suppression in children, or any visual changes. Avoid eyes. Pregnancy. Nursing mothers.

Beconase Aq Pharmacokinetics

See Literature

Beconase Aq Interactions

Not Applicable

Beconase Aq Adverse Reactions

Adverse Reactions

Nasal irritation, sneezing, headache, nausea, epistaxis, rhinorrhea.

Beconase Aq Clinical Trials

See Literature

Beconase Aq Note

Not Applicable

Beconase Aq Patient Counseling

See Literature